Linda A Parker Selected Research

PF 3845

1/2019	The ventral pallidum as a critical region for fatty acid amide hydrolase inhibition of nausea-induced conditioned gaping in male Sprague-Dawley rats.
10/2015	Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda A Parker Research Topics

Disease

57	Nausea 02/2022 - 04/2002
28	Vomiting 02/2022 - 01/2002
4	Cannabinoid Hyperemesis Syndrome 01/2022 - 01/2020
4	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 07/2012
3	Neoplasms (Cancer) 11/2021 - 03/2003
2	Shock 07/2017 - 03/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2021
1	Hyperthermia 01/2021
1	Chronic Disease (Chronic Diseases) 09/2020
1	Tobacco Use Disorder (Nicotine Dependence) 09/2020
1	Anhedonia 09/2020
1	Abdominal Pain (Pain, Abdominal) 06/2020
1	Familial cyclic vomiting syndrome 06/2020
1	Body Weight (Weight, Body) 02/2020
1	Diarrhea 02/2020
1	Brain Concussion (Cerebral Concussion) 01/2020
1	Inflammation (Inflammations) 11/2018
1	Hyperalgesia 11/2018
1	Pain (Aches) 11/2018
1	Edema (Dropsy) 11/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Obesity 01/2017
1	Medically Unexplained Symptoms 01/2016

Drug/Important Bio-Agent (IBA)

29	CannabinoidsIBA 11/2021 - 04/2002
17	Lithium ChlorideIBA 02/2022 - 04/2002
15	Dronabinol (THC)FDA LinkGeneric 01/2022 - 01/2004
14	AntiemeticsIBA 02/2022 - 07/2004
14	CannabidiolIBA 01/2022 - 04/2002
12	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 01/2004
10	cannabidiolic acidIBA 01/2021 - 08/2014
10	EndocannabinoidsIBA 07/2020 - 02/2008
9	Pharmaceutical PreparationsIBA 07/2020 - 10/2006
8	Ondansetron (Zofran)FDA LinkGeneric 07/2018 - 07/2004
8	LithiumIBA 02/2008 - 03/2003
7	Morphine (MS Contin)FDA LinkGeneric 02/2022 - 01/2002
7	muskIBA 02/2022 - 01/2002
7	EmeticsIBA 01/2014 - 04/2002
6	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2019 - 08/2011
5	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 03/2003
5	Monoacylglycerol LipasesIBA 07/2018 - 04/2012
4	Naloxone (Narcan)FDA LinkGeneric 02/2022 - 02/2020
4	5-HT1A Serotonin ReceptorIBA 01/2022 - 06/2011
4	SaccharinIBA 09/2020 - 06/2011
4	anandamide (arachidonylethanolamide)IBA 09/2020 - 02/2007
4	RimonabantIBA 11/2018 - 07/2004
4	Glycerol (Glycerine)FDA LinkGeneric 01/2016 - 04/2012
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2015 - 02/2007
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 09/2020
3	AmidesIBA 02/2022 - 09/2020
3	EstersIBA 01/2021 - 01/2018
3	N-oleoylglycineIBA 01/2021 - 01/2020
3	AutoreceptorsIBA 07/2018 - 05/2009
3	MJN110IBA 07/2018 - 02/2015
3	SolutionsIBA 09/2008 - 05/2003
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2022 - 09/2020
2	Alanine (L-Alanine)FDA Link 02/2022 - 09/2020
2	HU-580IBA 09/2020 - 01/2018
2	MK-886IBA 03/2020 - 10/2015
2	PF 3845IBA 01/2019 - 10/2015
2	GW 7647IBA 01/2019 - 11/2017
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 07/2018 - 03/2016
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018 - 06/2011
2	Aprepitant (Emend)FDA Link 01/2016 - 08/2014
2	AM 251 (AM251)IBA 10/2013 - 04/2012
2	Cannabinoid Receptor AgonistsIBA 08/2011 - 03/2003
2	Amphetamine (Amfetamine)FDA LinkGeneric 04/2007 - 01/2002
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2022
1	nabilone (Cesamet)FDA Link 11/2021
1	SugarsIBA 01/2021
1	PPAR alphaIBA 03/2020
1	AcidsIBA 03/2020
1	SC 24IBA 02/2020
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2020
1	CorticosteroneIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 11/2018
1	Transient Receptor Potential ChannelsIBA 11/2018
1	CarrageenanIBA 11/2018
1	1-(3-chlorophenyl)biguanideIBA 07/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 07/2018
1	tetralinIBA 01/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2018
1	Serotonin 5-HT1 Receptor AntagonistsIBA 01/2018
1	URB937IBA 11/2017
1	lorcaserinIBA 01/2017
1	5-HT2C Serotonin ReceptorIBA 01/2017
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2017
1	CB2 Cannabinoid ReceptorIBA 09/2016
1	HU 308IBA 09/2016
1	iodopravadoline (AM 630)IBA 09/2016
1	EnzymesIBA 03/2016
1	MonoglyceridesIBA 01/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	Neurokinin-1 Receptor AntagonistsIBA 08/2014
1	cannabidivarinIBA 10/2013

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 11/2021 - 04/2002
1	Baths 06/2020
1	Injections 01/2020
1	Oral Administration 09/2016
1	Therapeutics 04/2016